Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis

Respiratory Medicine

Volumn 100, Issue 10, 2006, Pages 1671-1681

  Arandjus, Claire ^a   Black, Peter N ^a   Poole, Phillippa J ^a   Wood Baker, Richard ^b   Steurer Stey, Claudia ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ROYAL HOBART HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bacterial; Chronic bronchitis; COPD; Exacerbations; Haemophilus influenzae; Oral vaccine

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL VACCINE; BACTERIUM LYSATE; HAEMOPHILUS INFLUENZAE VACCINE; IMMUNOMODULATING AGENT; LUIVAC; LW 50020; PLACEBO; SL 04; UNCLASSIFIED DRUG;

ABDOMINAL DISEASE; ACUTE DISEASE; BACTERIUM CULTURE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CAPSULE; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNIZATION; INCIDENCE; META ANALYSIS; METHODOLOGY; NONHUMAN; OUTCOMES RESEARCH; POISSON DISTRIBUTION; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZATION; REVIEW; SKIN DISEASE; SYSTEMATIC REVIEW; TABLET; URINARY TRACT DISEASE; URINARY TRACT INFECTION; VACCINATION;

ADMINISTRATION, ORAL; BACTERIAL VACCINES; BRONCHITIS; CHRONIC DISEASE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS;

EID: 33747843659     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.06.029     Document Type: Review

References (39)

1. Pauwels R.A., Buist A.S., Ma P., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 46 (2001) 798-825
2. National Heart Lung and Blood Institute. Morbidity and mortality: 2004 chartbook on cardiovascular, lung, and blood diseases (2004), US Department of Health and Human Services, MD
3. Britton M. The burden of COPD in the UK: results from the Confronting COPD survey. Respir Med 97 suppl. C (2003) S71-S79
4. Wouters E.F. Economic analysis of the confronting COPD survey: an overview of results. Respir Med 97 suppl. C (2003) S3-S14
5. Murray C.J., and Lopez A.D. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 274 (1996) 740-743
6. Mathers C., and Loncar D. Updated projections of global mortality and burden of disease, 2002-2030: data sources, methods and results, vol 2006 (2005), WHO, Geneva
7. Sullivan S.D., Ramsey S.D., and Lee T.A. The economic burden of COPD. Chest 117 (2000) S5-S9
8. Davies L., Hadcroft J., Mutton K., Earis J.E., and Kennedy N. Antimicrobial management of acute exacerbation of chronic airflow limitation. QJM 94 (2001) 373-378
9. Ekberg-Jansson A., Larsson S., and Lofdahl C.G. Preventing exacerbations of chronic bronchitis and COPD. BMJ 322 (2001) 1259-1261
10. Li J., Zheng J.P., Yuan J.P., Zeng G.Q., Zhong N.S., and Lin C.Y. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chin Med J (Engl) 117 (2004) 828-834
11. Pilette C., Durham S.R., Vaerman J.P., and Sibille Y. Mucosal immunity in asthma and chronic obstructive pulmonary disease: a role for immunoglobulin A?. Proc Am Thorac Soc 1 (2004) 125-135
12. Collet J.P., Shapiro P., Ernst P., Renzi T., Ducruet T., and Robinson A. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of acute respiratory infection by an immunostimulant. Am J Respir Crit Care Med 156 (1997) 1719-1724
13. Roth M., and Block L.H. Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines. Thorax 55 (2000) 678-684
14. Kyd J.M., and Cripps A.W. Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview. Vaccine 17 (1999) 1775-1781
15. Wybran J., Libin M., and Schandene L. Activation of natural killer cells and cytokine production in man by bacterial extracts. Immunopharmacol Immunotoxicol 11 (1989) 17-32
16. Lusuardi M., Capelli A., Carli S., et al. Local airways immune modifications induced by oral bacterial extracts in chronic bronchitis. Chest 103 (1993) 1783-11791
17. Nauek M., Matthys H., and Emmons L. The immunomodulators Broncho-Vaxom and Uro-Vaxom stimulate the bacterial killing and oxidative metabolism of polymorphonuclear leukocytes by the activation of phosphatidylinositol turnover. Int J Exp Clin Chemother 4 (1991) 1-11
18. Greenhalgh T. Papers that summarise other papers (systematic reviews and meta-analyses). BMJ 315 (1997) 672-675
19. Verhagen A.P., de Vet H.C., de Bie R.A., Boers M., and van den Brandt P.A. The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol 54 (2001) 651-654
20. Foxwell AR, Cripps AW, Dear KB. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. In: The Cochrane Library, issue 2. Chichester, UK: Wiley; 2003.
21. Steurer-Stey C., Bachmann L.M., Steurer J., and Tramer M.R. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest 126 (2004) 1645-1655
22. Clancy R., Cripps A., Murree-Allen K., Yeung S., and Engel M. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 2 (1985) 1395-1397
23. Clancy R.L., Cripps A.W., and Gebski V. Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae. Med J Aust 152 (1990) 413-416
24. Clancy R.L., and Cripps A.W. Specific protection against acute bronchitis associated with nontypeable Haemophilus influenzae. J Infect Dis 165 suppl. 1 (1992) S194-S195
25. Lehmann D., Coakley K.J., Coakley C.A., et al. Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. Am Rev Respir Dis 144 (1991) 324-330
26. Tandon M.K., and Gebski V. A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis. Aust N Z J Med 21 (1991) 332-427
27. Orcel B., Delclaux B., Baud M., and Derenne J.P. Preventive effect of an immunomodulator, OM-85 BV, on acute exacerbations of chronic bronchitis in elderly patients. Preliminary results at six months in 291 patients. Rev Mal Respir 10 (1993) 23-28
28. Germouty J. Immunotherapy of recurrent respiratory infections. Double-blind study of a new immunomodulator in 60 patients [in French]. Rev Pneumol Clin 42 (1986) 207-213
29. Cvoriscec B., Ustar M., Pardon R., et al. Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study. Respiration 55 (1989) 129-135
30. Djuric O., Mihailovic-Vucinic V., and Stojcic V. Effect of Broncho-Vaxom on clinical and immunological parameters in patients with chronic obstructive bronchitis: a double-blind, placebo-controlled study. Int J Immunother 5 (1989) 139-143
31. Keller R. Multicenter double-blind study of the action of Broncho-Vaxom in chronic bronchitis. Schweiz Med Wochenschr 114 (1984) 934-937
32. Ahrens J. Clinical effects of oral immunotherapy. Atemw Lungenkrkh 9 (1983) 424-427
33. Khedr M. Clinical and immunological efficacy of Broncho-Vaxom in chronic bronchitis: a double-blind study. Acta Ther 19 (1993) 49-60
34. Messerli C., Michetti F., Sauser-Hall P., et al. Effect of a bacterial lysate (Broncho-Vaxom) in the therapy of chronic bronchitis: multi-center double-blind clinical trial. Rev Med Suisse Romande 101 (1981) 143-146
35. Fischer H., Eckenberger H.P., van Aubel A., et al. Prävention von Infektrezidiven der oberen und unteren Luftwege [in German]. Atemw Lungenkrkh 18 (1992) 146-155
36. Orlandi O., Bruna S., and Bagnasco G. Immunostimulation treatment with a bacteriolysate in recurring bacterial infections in chronic bronchitics. Min Pneumol 22 (1983) 461-464
37. Rutishauser M., Pitzke P., Grevers G., van Aubel A., Elsasser U., and Kammereit A. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study. Adv Ther 15 (1998) 330-341
38. Tag El Din M., Ashmawi S., and Emam W.E.M. Effect of a polyvalent bacterial extract, Broncho-Vaxom, in the prophylaxis of acute exacerbations of chronic bronchitis. Eur J Clin Res 4 (1993) 99-105
39. Keller R., and Hinz G. Effect of an oral polyvalent bacterial lysate (Broncho-Vaxom) in chronic bronchitis [in German]. Prax Klin Pneumol 38 (1984) 225-228